BridgeMD
Tests treatment safety and results for Dupuytren's Disease
Official title Efficacy of Aponeurectomy on the 2-year Recurrence Rate of Dupuytren's Disease
ClinicalTrials.gov ID: NCT05067764
What this study is testing
- What it's testing
- Dupuytren's disease is a frequent hereditary disease in Northern Europe. It is a degenerative disease affecting the palmar aponeurosis of the hand.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years
- Carrier of Tubiana stage II-IV Dupuytren's disease on at least one or more rays, not previously operated
- Indication of a surgery by aponeurectomy
- Skin pinch of the posterior aspect of the arm of more than 1cm
- Affiliation to a social security system
You likely can't join if
- Previous surgery of any kind for Dupuytren's disease
- Involvement on the thumb only
- Need for a total skin graft or a pedicle flap on all the rays to be treated
- Active autoimmune disease
- Previous treatment with collagenase
- Pregnant and breastfeeding women
See the full eligibility criteria
- Age ≥ 18 years
- Carrier of Tubiana stage II-IV Dupuytren's disease on at least one or more rays, not previously operated
- Indication of a surgery by aponeurectomy
- Skin pinch of the posterior aspect of the arm of more than 1cm
- Affiliation to a social security system
- Patient informed of the study and having given informed consent
- Previous surgery of any kind for Dupuytren's disease
- Involvement on the thumb only
- Need for a total skin graft or a pedicle flap on all the rays to be treated
- Active autoimmune disease
- Previous treatment with collagenase
- Pregnant and breastfeeding women
- Patient under legal protection
- Contraindications to MRI (criteria applicable only for patients from the coordinating center, not applicable for other centers)
The study team makes the final eligibility decision.
Where it's taking place
- Pessac, France
- Saint-Herblain, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pessac, France; Saint-Herblain, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.